Physician profile
John T Capo
NPI 1982781209
$1,130,981.35
in general payments reported to CMS, 2019-2025
28 companies · $3,182 in 2025
The $3,182 reported for 2025 was more than what 88% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.1M · 2020: $17K · 2021: $1,208 · 2022: $4,069 · 2023: $4,169 · 2024: $2,453 · 2025: $3,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,550 · Travel and Lodging: $3,176 · Consulting Fee: $2,000 · Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,550.00 |
| Travel and Lodging | $3,176.41 |
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,077.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $1,062,802.43 | 2019 | |
| Axogen | $29,381.82 | 2019-2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Synthes Gmbh | $17,728.64 | 2019-2025 | |
| Medical Device Business Services, INC. | $10,691.89 | 2020 | |
| Synthes USA Products LLC | $5,927.23 | 2020 | |
| Skeletal Dynamics INC | $1,670.77 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $824.23 | 2024 | Iovera |
| Stryker Corporation | $506.87 | 2019-2022 | |
| Depuy Synthes Sales INC. | $321.09 | 2022-2025 | Na, Va-Lcp |
| Lifenet Health | $205.98 | 2019-2022 | |
| Acumed LLC | $188.87 | 2024 | Nanophix Implant, Inframe Implant, Innate Implant |
| Seapearl East, INC | $147.30 | 2023 | |
| Kerecis Limited | $134.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Dynasplint Systems INC. | $66.22 | 2019 | |
| Ferring Pharmaceuticals INC. | $57.73 | 2024-2025 | Euflexxa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $57.21 | 2019-2020 | |
| Davol INC. | $43.48 | 2024 | Channel Drain |
| Smith+Nephew, INC. | $35.07 | 2019 | |
| Integra Lifesciences Corporation | $30.22 | 2019 | |
| Conmed Corporation | $26.41 | 2024 | Airseal |
| Ossur Americas, INC. | $23.36 | 2024 | Miami J |
| Pacira Therapeutics, INC. | $17.87 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.28 | 2025 | |
| Endo USA, INC. | $17.00 | 2025 | Xiaflex |
| Daiichi Sankyo INC. | $14.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.75 | 2020 | |
| Horizon Therapeutics Plc | $14.29 | 2020 | |
| Braintree Laboratories, INC. | $13.75 | 2024 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Capo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.